| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 228,273 | 225,952 | 231,309 | 240,954 | | Cost of Revenue | 155,957 | 154,331 | 159,088 | 160,249 | | | Gross Profit | 72,316 | 71,621 | 72,221 | 80,705 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 65,129 | 62,084 | 63,410 | 65,784 | | Non Recurring |
-
|
-
|
-
| 129,409 | | Others | 2,829 | 2,885 | 3,040 | 3,174 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,358 | 6,652 | 5,771 | (117,662) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (272) | (275) | (349) | 195 | | Earnings Before Interest And Taxes | 4,086 | 6,377 | 5,422 | (117,467) | | Interest Expense |
-
|
-
|
-
| 565 | | Income Before Tax | 4,086 | 6,377 | 5,422 | (118,032) | | Income Tax Expense | 1,814 | 2,470 | 2,261 | (10,194) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,272 | 3,907 | 3,161 | (107,838) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (40) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,272 | 3,907 | 3,161 | (107,878) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,272 | $3,907 | $3,161 | ($107,878) |
|
0.49% Nasdaq 
0.25 (2.05%) 
Income Statement
